Ligand profile
ZINC104125601
Virtual-screening candidate from ZINC.
Bound to: KP13_31484 — 3-oxoacyl-[acyl-carrier-protein] synthase 2
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC104125601- UniProt (similar protein)
G3XDA2- Tanimoto
- 0.722
- Target protein
- KP13_31484
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 75.6
- −1 ≤ LogP ≤ 5 2.43
- MW ≤ 500 Da 271.3
- LogP ≤ 5 2.43
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 75.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
COC(=O)c1cccc(NC(=O)c2ccccc2)c1OCOC(=O)c1cccc(NC(=O)c2ccccc2)c1O
InChI=1S/C15H13NO4/c1-20-15(19)11-8-5-9-12(13(11)17)16-14(18)10-6-3-2-4-7-10/h2-9,17H,1H3,(H,16,18)InChI=1S/C15H13NO4/c1-20-15(19)11-8-5-9-12(13(11)17)16-14(18)10-6-3-2-4-7-10/h2-9,17H,1H3,(H,16,18)
QVEJBHQADUUANX-UHFFFAOYSA-NQVEJBHQADUUANX-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- 1LR
- Homolog
- G3XDA2
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC104125601 →
- ZINC ZINC20 ZINC104125601 →
- UniProt UniProt G3XDA2 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC104125601”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_31484.
PDB 13
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 15
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).